Skin Antiseptic Market Research, 2031
The global skin antiseptic market size was valued at $1,484.28 million in 2021 and is estimated to reach $3,060.81 million by 2031, growing at a CAGR of 7.5% from 2022 to 2031. Skin antiseptics are substances used to kill or inhibit the growth of microorganisms on the skin surface. These agents are used to prepare the skin before medical procedures to prevent infections. Skin antiseptics are essential for maintaining a sterile environment during surgical procedures and other invasive medical procedures.
The primary objective of using skin antiseptics is to reduce the number of microorganisms on the skin surface , as they can cause infections if entered in the body through a broken skin or invasion done for surgical procedure. By using skin antiseptics, healthcare providers can significantly reduce the risk of infections and their associated complications. Further, skin antiseptics are available in various forms, such as liquids, gels, sprays, and wipes. They contain active ingredients that are effective against a broad range of microorganisms. The most commonly used active ingredients in skin antiseptics include chlorhexidine, povidone-iodine, and alcohol.
“The skin antiseptic market was positively impacted during the lockdown period owing to rise in vaccination programs, which increased the demand for skin antiseptics. Moreover, post pandemic, rise in adoption of personal hygiene has shown positive impact on the growth of the market.”
Market Dynamics
The major factor driving the skin antiseptic market is the higher prevalence of hospital acquired infections (HAIs). These infections are caused by bacteria, viruses, and other microorganisms that patients can contract during their stay in a healthcare facility. HAIs can cause a range of illnesses, from mild to severe, and can even lead to death in some cases. To prevent HAIs, healthcare facilities must maintain high standards of hygiene, which includes the use of skin antiseptics. In addition, skin antiseptics are essential in reducing the risk of infection during invasive procedures such as surgeries and other medical procedures.
Moreover, the global antiseptic industry has witnessed a higher rate of growth due to increased expenditure on healthcare. With the growing healthcare industry, there is an increase in focus on improving the quality of care and reducing the incidence of infections. This is leading to an increased demand for antiseptics, including skin antiseptics.
Furthermore, rise in incidences of sports and road accident injuries is anticipated to drive the skin antiseptic market growth. As such injuries can lead to open wounds, abrasions and lacerations, which accounts to the high risk of infections due to the exposure to the external environment, soil, dust, and debris containing a range of microorganisms. Thus, skin antiseptics play an important role in reducing the risk of infections and promoting wound healing, which is expected to propel the market growth.
E-commerce (electronic commerce) has become a vital tool for small and large businesses globally, due to rise in preference of consumers for online shopping over traditional purchasing methods. Various animations through health apps to educate people regarding infection prevention and usage of wide range of skin antiseptic forms have contributed toward the growth of skin antiseptic market size. The demand for effective infection control solutions is not only limited to developed countries but is also being witnessed in the developing countries, such as China, Brazil, and India, which fuel the growth of the skin antiseptic market share. Moreover, an increase in promotional activities by manufacturers and growth in awareness for proper infection prevention and control among the general population are expected to fuel their adoption during the forecast period.
However, factor such as side effects associated with certain skin antiseptic restrains the growth of skin antiseptic market. In addition, permeability issue and allergic reactions associated with skin antiseptic hampers the growth of skin antiseptic market share. Furthermore, regulations on use of skin antiseptics containing alcohol-based formulations accounts to the minimization of side effects and thus provides lucrative opportunities to key players of the Skin antiseptic market.
The outbreak of COVID-19 disrupted growth in many economies across various domains. The pandemic positively impact the growth of skin antiseptic market. As the use of skin antiseptics was increased during the COVID-19 pandemic owing to prevent the spread of the virus. In addition, skin antiseptics were commonly used in healthcare settings to prevent infections during medical procedures, such as surgeries, and to prevent the spread of infections in hospitals. However, with the emergence of COVID-19, the use of skin antiseptics expanded beyond healthcare settings, thereby positively impacted to growth of market. Furthermore, hand sanitizers containing at least 60% alcohol are the most commonly used skin antiseptics for the disinfection of skin. They are effective in killing most types of viruses and bacteria, including the COVID-19 virus. In addition to hand sanitizers, other skin antiseptics, such as alcohol-based wipes and sprays, are also being used as skin antiseptic. Thus, pandemic positively impacted to growth of market.
Segmental Overview
The skin antiseptic market is segmented into type, form, distribution channel, and region. On the basis of type, the market is categorized into alcohol, chlorhexidine, iodine, and others. On the basis of form, the market is classified into solutions, cream, swab sticks, and others. On the basis of distribution channel, the market is segregated into hospital pharmacies, online providers, and drug stores and retail pharmacies. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
By Type
The skin antiseptic market is categorized into alcohol, chlorhexidine, iodine and others. The alcohol segment accounted for the largest share in terms of revenue in 2021 and is expected to witness highest CAGR during the forecast period, owing to increased usage of alcohol skin antiseptics during surgical procedures and rise in number of key players offering alcohol-based skin antiseptic. In addition, alcohol-based skin antiseptic are effective against wide range of microbes, thereby are highly adopted as compared to other skin antiseptic.
By Form
The skin antiseptic market is categorized into the market is categorized into solutions, cream, swab sticks, and others. The solution segment accounted for largest share in terms of revenue in 2021 owing to wide availability of antiseptic solution and increase in adoption of antiseptic solutions in pre-operation and pre-injection skin preparation. The others segment is projected to register highest CAGR during forecast period owing to rise in adoption of other form of antiseptic such as wipe skin antiseptic during surgeries and number of key players offering wipe and soap form of skin antiseptic.
By Distribution Channel
The skin antiseptic industry is categorized into hospital pharmacies, drug stores and retail pharmacies and online providers. The drug stores and retail pharmacies segment occupied highest share in 2021 and is expected to remain dominant during forecast period owing to accessibility of retail pharmacies everywhere and large chain of distribution networks. The online providers segment is projected to register highest CAGR during forecast period owing to rise in popularity of online pharmacy and number of users preferring online pharmacies.
By Region
The skin antiseptic industry is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for largest share in terms of revenue in 2021 and is expected to remain dominant during the forecast period owing to rise in number of surgical procedures and presence of major players offering skin antiseptic. In addition, rising prevalence of hospital acquired infections (HAIs) such as central line-associated bloodstream infections (CLABSIs) are expected to drive the market. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in implementation of infection control measures, rise in number of surgical site infections and availability of wide range of skin antiseptic products, thereby driving the growth of market during the forecast period.
Presence of several major players, such as Cardinal Health Inc., Becton, Dickinson and Company, 3M Company, and B. Braun SE. and advancement in manufacturing technology for development of effective form of skin antiseptics in the region is expected to drive the growth of market. Furthermore, the presence of well-established healthcare infrastructure, and the rise in adoption rate of wide range of dosage forms such as wipes, swabstick, spary, and gels are expected to drive the market growth. Furthermore, various product approval and contract agreements as key strategies adopted by the key players in this region further boost the growth of the market.
Asia-Pacific is expected to grow at the highest rate during the forecast period. The market growth in this region is attributable to the presence of key players in the region. Moreover, the rise in incidences of road accidents results in demand for primary care such as disinfecting the wounds by using skin antiseptics, which is expected to drive the growth of the market. For instance, according to a report by the Ministry of Road Transport and Highways – India 2021, there was a 12.6% rise in road accidents as compared to 2020. Thus, rise in incidences of accidental injuries is expected to drive the market growth.
Further, many countries such as India, Australia and UK, the increasing government initiative in awareness and guidelines regarding infection prevention and control is anticipated to drive the market growth. Asia-Pacific offers profitable opportunities for key players operating in the Skin antiseptic market, thereby registering the fastest growth rate during the skin antiseptic market forecast, owing to the growing infrastructure of industries, rising in demand of skin antiseptics to reduce the risk of infections, as well as well-established presence of domestic companies in the region. In addition, the rise in contract manufacturing organizations within the region provides great opportunity for new entrants in this region.
Competition Analysis
Competitive analysis and profiles of the major players in the Skin antiseptic market, such as Cardinal Health Inc., Becton, Dickinson and Company, B. Braun SE, 3M Company, Ecolab, Mölnlycke Health Care AB, Xttrium Laboratories, SIRMAXO CHEMICALS PVT.LTD., Schülke & Mayr GmbH, PDI, Inc. are provided in this report. Major players have adopted product approval, launch, business expansion, and acquisition as key developmental strategies to improve the product portfolio of the Skin antiseptic market.
Recent Product Approval in Skin antiseptic market
- In April 2019, BD (Becton, Dickinson and Company), a leading global medical technology company, announced that it received U.S. Food and Drug Administration (FDA) approval for BD ChloraPrep skin preparation with sterile solution, the only fully sterile chlorhexidine gluconate (CHG) antiseptic skin preparation commercially available in the U.S.
Product Launch in Skin Antiseptic Market
- In July 2020, BD (Becton, Dickinson and Company) a leading global medical technology company, announced the launch of BD PurPrep patient preoperative skin preparation with sterile solution, the first and only fully sterile povidone-iodine plus isopropyl alcohol single-use antiseptic skin preparation commercially available in the United States.
Business Expansion in Skin Antiseptic Market
- In March 2019- PDI, a leader in infection prevention products and solutions for its customers, officially opened the doors to its new global headquarters in Bergen County, NJ. The new headquarters represents the continued investment in PDI’s products and customer solutions, and its dedication to R&D.
Partnership in Skin Antiseptic Market
- In January 2022, PDI announced a strategic partnership with the Association for Professionals with goal to advance the science and practice of infection prevention and control in healthcare facilities
Acquisition in Skin Antiseptic Market
- In September 2022- Schülke Group, a leading global provider in the fields of infection prevention and hygiene solutions in healthcare, announced the acquisition of the Spanish company Vesismin Health based in Barcelona specialized in hospital infection control.
Key Benefits For Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the skin antiseptic market analysis from 2021 to 2031 to identify the prevailing skin antiseptic market opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the skin antiseptic market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global skin antiseptic market trends, key players, market segments, application areas, and market growth strategies.
Skin Antiseptic Market, by Type Report Highlights
| Aspects | Details |
 Market Size By 2031 | USD 3.1 billion |
 Growth Rate | CAGR of 7.5% |
 Forecast period | 2021 - 2031 |
 Report Pages | 300 |
 By Type |
|
 By Form |
|
 By Distribution Channel |
|
 By Region |
|
 Key Market Players | Xttrium Laboratories, B. Braun SE, 3M Company, SIRMAXO CHEMICALS PVT.LTD., Ecolab Inc., Cardinal Health Inc., Becton, Dickinson and Company, PDI, Inc., Schülke & Mayr GmbH, Molnlycke Health Care AB |
Analyst Review
This section provides various opinions of top-level CXOs in the global skin antiseptic market. According to the insights of CXOs, increase in demand for skin antiseptic and rise in number of hospitals acquired infection (HAIs) are expected to offer profitable opportunities for the expansion of the market. In addition, favorable government initiatives and higher spending for infection control have piqued the interest of several companies to develop skin antiseptic.
CXOs further added that increase in number of key players offering various forms of skin antiseptic such as wipes, swabs, and antiseptic soaps are expected to boost the growth of market. In addition, rise in number of surgeries carried out every year across the globe results in demand for skin antiseptic, thus driving the growth of market.
Furthermore, North America accounted for the largest share in terms of revenue in 2021 and is expected to remain dominant during the forecast period owing to rise in number of surgical procedures and presence of major players offering skin antiseptic. In addition, increase in prevalence of hospital acquired infections (HAIs) such as central line-associated bloodstream infections (CLABSIs) are expected to drive the market. However, Asia-Pacific is anticipated to witness notable growth, owing to rise in implementation of infection control measures, surge in number of surgical site infections, and availability of wide range of skin antiseptic products, thereby driving the growth of market during the forecast period.
The skin antiseptics are used to disinfect and clean the skin to reduce the risk of infection.
The base year is 2021 in skin antiseptic market.
The major factor that fuels the growth of the skin antiseptic market are increase in number of surgeries, surge in prevalence of hospital acquired infections (HAIs) and rise in awareness regarding infection control measures.
Infection leading application of Skin Antiseptic Market.
North America is the largest regional market for Skin Antiseptic.
The total market value of skin antiseptic market is $1484.28 million in 2021.
Top companies such as, Sirmaxo Chemicals Pvt.Ltd, 3M Company, Becton, Dickinson and Company and Cardinal Health Inc., held a high market position in 2021. These key players held a high market position owing to the strong geographical foothold in North America, Europe, Asia-Pacific, and LAMEA.
Loading Table Of Content...
Loading Research Methodology...
